Sorted By:

Relevance


New Study: Patient cost sharing rising as plans push more costs to patients through deductibles, coinsurance

PhRMA  |  Blog Post

   [1] Kaiser/HRET data, “Among Covered Workers with a General Annual Health Plan Deductible for Single Coverage, Average Deductible, by Plan Type, 2006-2015,” available at http://kff.org/health-costs/report/2015-employer-health-benefits-survey/view/exhibits/ [2] Kaiser/HRET data for 2007 and 2015.
http://catalyst.phrma.org/new-study-patient-cost-sharing-rising-as-plans-push-more-costs-to-patients-through-deductibles-coinsurance

New Jersey

Access Better Coverage  |  From Our Network

Enforcing non-discrimination requirements, which apply to benefit design and provider networks;  Establishing stronger rules regarding exceptions and appeals processes, which help enrollees get the medicines and care their doctors recommend; and   Enhancing the state's marketplace website or advocating for a Healthcare.gov page that allows for easier plan comparisons, including searchable formularies and estimates of total out-of-pocket costs.
http://www.accessbettercoverage.org/states/new-jersey

New PhRMA Report: Medicines in development for patients with rare diseases demonstrate the promise of innovation

PhRMA  |  Blog Post


http://catalyst.phrma.org/new-phrma-report-medicines-in-development-for-patients-with-rare-diseases-demonstrate-the-promise-of-innovation

PhRMA Statement on the Passing of Sen. Ted Kennedy

PhRMA  |  Press Release

PhRMA members alone invested an estimated $50.3 billion in 2008 in discovering and developing new medicines.
http://www.phrma.org/press-release/phrma-statement-on-the-passing-of-sen-ted-kennedy

VIDEO: PhRMA CEO joins Fox Business anchor Neil Cavuto to discuss personal connection to value of innovation and White House meeting

PhRMA  |  Blog Post

Visit .com/?
http://catalyst.phrma.org/video-phrma-ceo-joins-fox-business-anchor-neil-cavuto-to-discuss-personal-connection-to-value-of-innovation-and-white-house-meeting

Medicare Monday: What does Medicare Part B Cover?

PhRMA  |  Blog Post

Check back with Medicare Monday for more on Part B and other aspects of Medicare next week.
http://catalyst.phrma.org/medicare-monday-what-does-medicare-part-b-cover

New Hampshire

Access Better Coverage  |  From Our Network

Enforcing non-discrimination requirements, which apply to benefit design and provider networks;  Establishing stronger rules regarding exceptions and appeals processes, which help enrollees get the medicines and care their doctors recommend; and   Enhancing the state's marketplace website or advocating for a Healthcare.gov page that allows for easier plan comparisons, including searchable formularies and estimates of total out-of-pocket costs.
http://www.accessbettercoverage.org/states/new-hampshire

New PhRMA report: New medicines in development for autoimmune diseases offer patients hope for brighter futures

PhRMA  |  Blog Post

View the full report here.
http://catalyst.phrma.org/new-phrma-report-new-medicines-in-development-for-autoimmune-diseases-offer-patients-hope-for-brighter-futures

New PhRMA Report: Medicines in development offer hope for osteoporosis patients and families

PhRMA  |  Blog Post

  View the full report here: http://phrma.org/sites/default/files/pdf/medicines-in-development-report-osteoporosis.pdf
http://catalyst.phrma.org/new-phrma-report-medicines-in-development-offer-hope-for-osteoporosis-patients-and-families

Innovative Oncology Medicines Have Led to Impressive Gains in Patient Survivorship

PhRMA  |  Press Release

“With more than 5,000 medicines in the biopharmaceutical pipeline, including more than 3,000 potential medicines for cancer patients, the future looks bright for continued progress.
http://www.phrma.org/press-release/innovative-oncology-medicines-have-led-to-impressive-gains-in-patient-survivorship

Jonathan S. Leff

PhRMA  |  Biography

Leff is a member of several not-for-profit Boards, including the Spinal Muscular Atrophy Foundation, Friends of Cancer Research, and the Columbia University Medical Center Board of Advisors.
http://www.phrma.org/biography/jonathan-s-leff

Study finds actual cost of 14 new medicines is billions less than predicted

PhRMA  |  Blog Post

Read more about PhRMA’s policy solutions to deliver innovative treatments to patients here.
http://catalyst.phrma.org/study-finds-actual-cost-of-14-new-medicines-is-billions-less-than-predicted

New report highlights more than 250 vaccines in development

PhRMA  |  Blog Post

View the full report here.
http://catalyst.phrma.org/new-report-highlights-more-than-250-vaccines-in-development

Medicare Monday: Did You Know Four out of Five Part D Prescriptions Are Generic?

PhRMA  |  Blog Post


http://catalyst.phrma.org/medicaremonday-did-you-know-four-out-of-five-part-d-prescriptions-are-generic

World IP Day: Celebrating the protections that allow innovation to thrive

PhRMA  |  Blog Post

This World IP Day, we hope America continues their commitment to the life sciences industry and the advancement of new treatments.
http://catalyst.phrma.org/world-ip-day-celebrating-the-protections-that-allow-innovation-to-thrive

Celebrating cardiovascular health on World Heart Day 2015

PhRMA  |  Blog Post

As we celebrate World Heart Day, it is important to remember the role of continued innovation in reducing the impact of heart disease and helping patients live longer, healthier lives.
http://catalyst.phrma.org/celebrating-cardiovascular-health-on-world-heart-day-2015

New report highlights more than 250 vaccines in development

PhRMA  |  Blog Post

View the full report here.
http://catalyst.phrma.org/new-report-highlights-more-than-250-therapeutic-and-preventative-vaccines-in-development

Strong R&D Investment the Best Bet to Slow Alzheimer’s Growing Threat

PhRMA  |  Blog Post

Many researchers believe that early treatment and diagnosis will be the best way to beat the disease but until there is a simple definitive diagnostic test it is challenging to conduct trials with Alzheimer’s patients, particularly those who do not yet have symptoms.
http://catalyst.phrma.org/strong-rd-investment-the-best-bet-to-slow-alzheimers-growing-threat

Paul A. Aines Named PhRMA Executive Vice President and Chief Financial Officer; Del Persinger to Retire

PhRMA  |  Press Release

Connect with PhRMA For information on how innovative medicines save lives, please visit: www.PhRMA.orgwww.FromHopetoCures.orgwww.Facebook.com/PhRMAwww.Twitter.com/PhRMA
http://www.phrma.org/press-release/paul-a-aines-named-phrma-executive-vice-president-and-chief-financial-officer-del-persinger-to-retire

New Medicine Approvals 2015 Report

PhRMA  |  Report

The new medicines approved by the FDA in 2015 demonstrate the tireless work of America’s biopharmaceutical researchers and scientists to deliver on the promise of science.
http://www.phrma.org/report/new-medicine-approvals-2015-report

Rep. Clyburn among speakers at “Research in Your Backyard” press conference

PhRMA  |  Press Release

“Clinical trials provide an important message of hope for patients who seek new treatment for unmet medical needs.
http://www.phrma.org/press-release/rep-clyburn-among-speakers-at-research-in-your-backyard-press-conference

PhRMA Board of Directors Elects New Officers, Welcomes New Member Company

PhRMA  |  Press Release

“Helping patients and addressing the burden of disease is what drives the men and women of this industry every single day,” said Bradway.
http://www.phrma.org/press-release/phrma-board-of-directors-elects-new-officers-welcomes-new-member-company

Medicamentos en Desarrollo para la Diabetes

PhRMA  |  Report

Para muchos pacientes, un diagnóstico de diabetes afecta casi todos los aspectos de, su vida, incluidas las preocupaciones de una dieta especial y otros cambios en el estilo de vida, así como los medicamentos que a diario deben tomar para manejar los niveles de glucosa en la sangre.
http://www.phrma.org/report/medicamentos-en-desarrollo-para-la-diabetes

PhRMA Foundation Launches New Web Platform

PhRMA  |  Blog Post

Later this year, we’ll be launching educational modules for health care professionals developed in partnership with the National Institutes of Health (NIH) and the American Society of Clinical Pharmacology and Therapeutics (ASCPT).
http://catalyst.phrma.org/phrma-foundation-launches-new-web-platform

Fran Cogen, MD, CDE

PhRMA  |  Biography

Originally from New York, she has lived in the Washington, DC, area since 1996.
http://www.phrma.org/biography/fran-cogen-md-cde

You have reviewed the first 100 results out of 1971. Each page contains 25 results. You're on page 4.

prev 1 2 3 4 5 6 next